FDA
Mounjaro Is Now Approved to Lower the Risk of Heart Events
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
Moderna and Merck's personalized mRNA cancer vaccine reduced melanoma recurrence and metastasis in a Phase 3 trial. The companies plan to seek FDA approval.
Who Is Heidi Overton, Trump's Nominee to Lead the FDA?
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
A robot could eventually conduct your blood draw at the doctor's office
The US Food and Drug Administration has approved a new product aimed at automating blood draws in outpatient situations. Aletta is a standalone robotic device capable of drawing blood from a patient's arm. It uses near-infrared light and Doppler ultrasound to identify a vein and then automates the other processes of a blood draw, such as applying a tourniquet, inserting and disposing of a needle and placing a bandage on the patient. A trained phlebotomist must begin the procedure and oversee the device while it is in use, but a single person can monitor up to three Aletta robots at once. "Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists." said Michelle Tarver, director of the FDA's Center for Devices and Radiological Health. The approval for Aletta was granted based on clinical data showing it was capable of successful blood draws at rates comparable to or better than a phlebotomist.
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
The Trump Administration Wants More Food Ingredient Disclosure
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
FDA Approves the First mRNA Flu Vaccine
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
FDA panel loosens restrictions for controversial peptides popular online
A US Food and Drug Administration (FDA) advisory panel has voted to loosen restrictions on controversial peptides that have become popular online, but have not been well researched for human usage. The panel narrowly voted to allow specialised pharmacies to produce drugs including BPC-157, TB-500 and KPV, a major regulatory hurdle towards making them available via prescription. Peptides are small proteins that our bodies normally produce and that have long been used to treat medical conditions, including diabetes. But unregulated injectable peptides have exploded in the online wellness community - including among many young influencers - since GLP-1s (weight loss drugs) became mainstream. The FDA does not have to follow the panel's recommendations, but often does.
An FDA Committee Just Voted in Favor of Peptides--Despite the Agency's Opposition
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
Taylor Farms Spent Big on MAGA and Anti-Regulatory Lobbying Before Diarrhea Outbreak
The company donated more than $3.6 million to conservative groups between 2020 and 2025, including $1 million to the MAGA Inc. super PAC. The lettuce supplier at the center of the turbo diarrhea outbreak has spent millions of dollars to sway sentiment around food regulation and elect Donald Trump and other MAGA Republicans, according to public filings. Taylor Farms donated more than $2 million to conservative political groups in 2025, according to Federal Election Commission filings. That includes a $1 million donation to MAGA Inc., the Trump-centric super PAC, and $1.1 million to other super PACs dedicated to electing Republicans. From 2020 through the end of 2024, the company donated more than $1.6 million to conservative PACs, including a total of $850,000 to AFP Action, an anti-regulation super PAC with ties to the Koch network.